We further evaluated the association between CIP2A staining and pre-treatment clinical prostate cancer risk group stratification based on PSA values, Gleason scores and clinical tumor staging [7] among patients treated by radical prostatectomy (n = 31). The gene discussed is KLK3; the disease is Familial prostate cancer.